Financial

CARMAT Completes a €7 Million Capital Increase With Several Historical Financial Shareholders

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aimed at providing a therapeutic alternative for patients suffering from advanced biventricular heart failure (the “Company” or “CARMAT“), today announced the completion of a capital increase for a total amount of €7 million, subscribed in its […]

Cordis issues statement on the CMS announcement to expand coverage of carotid stenting

Miami Lakes, 10/16/2023 – Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, strongly supports the decision made by the Centers for Medicare & Medicaid Services (CMS) to expand coverage of carotid artery stenting (CAS) cms.gov. This expansion in coverage will allow patients that suffer […]

Cardio Diagnostics Holdings, Inc Launches New Lab and Fulfillment Center, Paving Way for Expanded Testing Capacity, Reduced Costs, Reduced Turnaround Time and Improved Margins

CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced the launch of the Company’s new integrated facility in Iowa City, Iowa. This facility will house Cardio Diagnostics’ new research laboratory, high-complexity Clinical Laboratory Improvement Amendments (CLIA) laboratory, and fulfillment center, serving as […]

VarmX Promotes CSO Dr. Jeffrey Lawson to New CEO and Moves to New State-of-the-Art Facility

LEIDEN, The Netherlands–(BUSINESS WIRE)–VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces that Dr. Jeffrey Lawson, currently the Company’s Chief Scientific Officer, will assume the role of CEO, succeeding Dr. Jan Öhrström who will continue as Chairman. “Jeff’s extensive background as […]

Hyperfine, Inc. Announces Promotions of Two Key Clinical Affairs Executives

GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced the promotions of neuroradiologists, Dr. Edmond Knopp and Dr. Chip Truwit. Effective immediately, Drs. Knopp and Truwit will be […]

Vektor Medical Strengthens Its Medical Advisory Board with World-renowned Leaders in Electrophysiology

SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a pioneer in arrhythmia care and developer of the only FDA-cleared non-invasive technology to accurately map arrhythmias using just 12-lead ECG data, is delighted to announce the expansion of its esteemed Medical Advisory Board. The newly expanded Medical Advisory Board, features preeminent electrophysiology leaders, including: Dr. […]

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

ANDOVER, Mass., Oct. 10, 2023 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on October 5, 2023, TransMedics granted non-qualified stock options to purchase an aggregate of 105,119 shares of its common stock […]

Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc.

BOSTON, Oct. 10, 2023 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, and OpSens, Inc. (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that they have entered into a definitive agreement under which […]

CorWave Announces the Grand Opening of Its Manufacturing Facility on the Banks of the Seine, next to Paris

CLICHY, France–(BUSINESS WIRE)–CorWave, a French company that develops and manufactures innovative cardiac assist devices, held the grand opening of its new facility on the banks of the Seine in Clichy, next to Paris, on Monday, October 9th. The company occupies over 2,400m² of production, laboratory, and office space, bringing together […]